Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.
about
Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesFormaldehyde-treated, heat-inactivated virions with increased human immunodeficiency virus type 1 env can be used to induce high-titer neutralizing antibody responses.Comparing antigenicity and immunogenicity of engineered gp120.Characterization of the effects of aryl-azido compounds and UVA irradiation on the viral proteins and infectivity of human immunodeficiency virus type 1Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1).Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.Clinical experience with therapeutic AIDS vaccines.First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.Evaluation of Mycoplasma inactivation during production of biologics: egg-based viral vaccines as a model.Detection of antibodies specific to the non-structural proteins of fowl adenoviruses in infected chickens but not in vaccinated chickens.
P2860
Q33683203-AA15CFD3-0CAB-4EE6-AE18-AE06FC73212BQ33911809-7ADDA5D5-F63D-488B-9A71-0A886CDC323AQ33984309-5C67D44D-2BE6-494A-A02B-C344537241CDQ34283113-0D4964B6-9915-4489-A4EE-A8BBC5192373Q35076987-9FE2BA9D-7F6F-4238-9E98-490B8484E79EQ35154031-44EE528C-F1EC-4A50-9080-DD888332F4F8Q35478282-990A01BC-F670-4A1B-8C23-561F198DF3CCQ35745442-4D49B685-41B9-402A-86A4-467C051B122EQ36009232-6CDBA0EA-E810-4ACE-A004-3EAD663B8F09Q36149102-7DC58AD1-4BDA-48B3-94B8-BF86BEE82FEBQ36198648-EC192E23-7A85-42A8-A029-D3E98448F0FCQ37449883-5746962A-D162-4D05-9844-BE377E83CB56Q38032879-694CAA0C-504E-44DB-A636-BB6B9F813238Q39402539-AB337AD3-0F37-42E6-BC3A-30B5A7F24EFEQ40122953-6AB3FBD0-D4A8-47DF-9216-F1058F8FE62FQ40329438-CE65B574-361C-4CEF-A0CD-1BDB2F2DEE1CQ42270583-6A814903-FE39-4789-AC8C-DEAA3B053BF4
P2860
Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Induction of humoral immune re ...... immunodeficiency virus type 1.
@ast
Induction of humoral immune re ...... immunodeficiency virus type 1.
@en
type
label
Induction of humoral immune re ...... immunodeficiency virus type 1.
@ast
Induction of humoral immune re ...... immunodeficiency virus type 1.
@en
prefLabel
Induction of humoral immune re ...... immunodeficiency virus type 1.
@ast
Induction of humoral immune re ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Induction of humoral immune re ...... immunodeficiency virus type 1.
@en
P2093
C Petropoulos
I S Y Chen
J T Safrit
K Grovit-Ferbas
P2860
P304
P356
10.1128/JVI.79.8.4927-4935.2005
P577
2005-04-01T00:00:00Z